The Limited Times

Now you can see non-English news...

Corona drug: Researchers have great hope - will a German llama save the world?

2020-06-06T11:53:33.325Z


Coronavirus drugs: Remdesivir vs. Hydroxychloroquine research shows clear trends for efficacy - approvals are also being expanded in Europe. 


Coronavirus drugs: Remdesivir vs. Hydroxychloroquine research shows clear trends for efficacy - approvals are also being expanded in Europe. 

  • Medicines are searched worldwide in connection with the coronavirus * .
  • Research * is apparently making progress.
  • A study from the United States is now showing clear success with the use of the drug remdesivir .
  • Here you will find the basic facts about the corona virus * and the corona news from Germany. We also offer you the current number of cases in Germany on a map. The following recommendations for Corona protective measures * are currently available.

Update June 5: The research for a drug to treat Covid-19 is operated feverishly for months. The scientists quickly focused on two substances that were originally developed to combat other diseases. 

The Ebola drug Remdesivir had emerged as a favorite. Without causing serious side effects, it significantly reduced the subjects' recovery time. The death rate also fell slightly in the tests. In the United States, Remdesivir was promptly approved for emergencies

That the substance helps is certainly a gratifying finding, but it has only been found as a temporary solution. The search for a drug specially tailored to the coronavirus is still in full swing.

Coronavirus: Research into drugs on the right track - does a llama make the breakthrough?

Researchers in Sweden now have great hope after examining a llama that they had flown in from a German research farm in Germany. Is it the key to finding a treatment for lung disease ?

+

Coronavirus: Is a Llama the Key to Researching a Drug?

© dpa / Stefan Sauer

The chances are obviously very good, reports the German press agency . The animal was immunized with virus proteins and produced tiny antibodies . Alpacas and other camel species can develop this special type of blood cell. The so-called nano-antibodies are now the cornerstone for further research

The scientists' joyful observation: The llama antibodies attached themselves to the same part of the virus as do human beings. They can be isolated from the blood of the animals and then, the researchers hope, used to treat corona sufferers . However, tests on mice and hamsters are still pending. 

Coronavirus research: drug shows first clear successes - expansion of use planned

Initial report of May 23: USA - While the number of worldwide from infection with the coronavirus has increased convalescent to over two million, should reduce the number of new cases still remain on high worldwide. South America in particular is coming into focus: It has now replaced Europe as the focus of the pandemic.

As time progresses, more and more studies on therapeutic approaches and treatment options are published. They confirm initial assumptions - or dispel myths. Two recent findings give hope that doctors will soon have more clarity.

Another German researcher is now checking whether the coronavirus is also attacking the brain.

Coronavirus drug: Extension of approval in Europe could be imminent

As the ZDF writes, there are two main tendencies: According to this, the drug originally developed for malaria, hydroxychloroquine, had serious side effects, especially for people with heart problems, and rather increased mortality rates. At the same time, there would be confirmation of treatment success with another drug that was originally intended to be used against Ebola. 

Accordingly, clear treatment successes are particularly evident : the death rate after using Remdesivir - compared to placebo - is somewhat lower, the recovery time is 31 percent lower. In the United States, the  US biotech group Gilead has already received approval for the drug in emergencies. And the EU drug agency EMA could soon follow suit. In a hearing before the EU Parliament last week, it was certified that experts rate the study data available so far as "robust enough". If this is the case, a conditional market approval could be imminent. The medication may already be used in Europe for inpatients who are not ventilated.

A study on Remdesivir * has also been running in Germany for some time. The drug is being researched at eight German university clinics. Also in Munich. Here the drug helped about every second patient, reported Professor Wendtner, chief physician of infectiology at the Munich clinic in Schwabing.

Coronavirus drug: Research continues in different directions

A publication by the National Health Institute in the USA (NIH) shows that testing is continuing in different directions at university clinics and in cooperation with various pharmaceutical companies: on May 14, it was confirmed that another study on hydroxychloroquine should also start. Apparently, the doctors hope to find out about the effects in connection with the antibiotic azithromycin . The participants in the study should take the medication at home and document their condition.

Report about our work @MpiciPotsdam @BioMolSys on sorting out whether artemisia annua extracts and pure substances might actually work against coronavirus. We need to get certainty at a time when entire countries are beginning to use untested extracts. https://t.co/1E4wCWFW67

- Peter Seeberger (@peterseeberger) May 14, 2020

Meanwhile, researchers from the Max Planck Institute in Berlin are following another trail . Here it is examined whether extracts of artemisinin (or mugwort) could prove to be effective. A medicinal potion based on this plant is now marketed worldwide from Madagascar - since scientific evidence has so far been lacking, researchers at the Max Planck Institute hope for more clarity here.

* merkur.de is part of the nationwide Ippen-Digital editors network

List of rubric lists: © dpa / Stefan Sauer

Source: merkur

All news articles on 2020-06-06

You may like

Trends 24h

News/Politics 2024-03-27T16:45:54.081Z
News/Politics 2024-03-28T06:04:53.137Z

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.